Literature DB >> 26277364

Stroke: advances in medical therapy and acute stroke intervention.

Kevin M Barrett1, Brajesh K Lal, James F Meschia.   

Abstract

Evidence-based therapeutic options for stroke continue to emerge based on results from well-designed clinical studies. Ischemic stroke far exceeds hemorrhagic stroke in terms of prevalence and incidence, both in the USA and worldwide. The public health effect of reducing death and disability related to ischemic stroke justifies the resources that have been invested in identifying safe and effective treatments. The emergence of novel oral anticoagulants for ischemic stroke prevention in atrial fibrillation has introduced complexity to clinical decision making for patients with this common cardiac arrhythmia. Some accepted ischemic stroke preventative strategies, such as carotid revascularization for asymptomatic carotid stenosis, require reassessment, given advances in risk factor management, antithrombotic therapy, and surgical techniques. Intra-arterial therapy, particularly with stent retrievers after intravenous tissue plasminogen activator, has recently been demonstrated to improve functional outcomes and will require investment in system-based care models to ensure that effective treatments are received by patients in a timely fashion. The purpose of this review is to describe recent advances in medical and surgical approaches to ischemic stroke prevention and acute treatment. Results from recently published clinical trials will be highlighted along with ongoing clinical trials addressing key questions in ischemic stroke management and prevention where equipoise remains.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26277364     DOI: 10.1007/s11886-015-0637-1

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  29 in total

1.  Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials.

Authors:  Maurizio Paciaroni; Giancarlo Agnelli; Sara Micheli; Valeria Caso
Journal:  Stroke       Date:  2007-01-04       Impact factor: 7.914

2.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Europace       Date:  2012-08-24       Impact factor: 5.214

Review 3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

4.  Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

Authors:  Brian F Gage; Yan Yan; Paul E Milligan; Amy D Waterman; Robert Culverhouse; Michael W Rich; Martha J Radford
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

5.  Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis.

Authors:  Gregory Y H Lip; Felicita Andreotti; Laurent Fauchier; Kurt Huber; Elaine Hylek; Eve Knight; Deirdre Lane; Marcel Levi; Francisco Marín; Gualtiero Palareti; Paulus Kirchhof
Journal:  Thromb Haemost       Date:  2011-11-02       Impact factor: 5.249

Review 6.  Stroke prevention in atrial fibrillation: a systematic review.

Authors:  Gregory Y H Lip; Deirdre A Lane
Journal:  JAMA       Date:  2015-05-19       Impact factor: 56.272

7.  Endovascular therapy for ischemic stroke with perfusion-imaging selection.

Authors:  Bruce C V Campbell; Peter J Mitchell; Timothy J Kleinig; Helen M Dewey; Leonid Churilov; Nawaf Yassi; Bernard Yan; Richard J Dowling; Mark W Parsons; Thomas J Oxley; Teddy Y Wu; Mark Brooks; Marion A Simpson; Ferdinand Miteff; Christopher R Levi; Martin Krause; Timothy J Harrington; Kenneth C Faulder; Brendan S Steinfort; Miriam Priglinger; Timothy Ang; Rebecca Scroop; P Alan Barber; Ben McGuinness; Tissa Wijeratne; Thanh G Phan; Winston Chong; Ronil V Chandra; Christopher F Bladin; Monica Badve; Henry Rice; Laetitia de Villiers; Henry Ma; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis
Journal:  N Engl J Med       Date:  2015-02-11       Impact factor: 91.245

8.  Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study.

Authors:  Lars Marquardt; Olivia C Geraghty; Ziyah Mehta; Peter M Rothwell
Journal:  Stroke       Date:  2009-11-19       Impact factor: 7.914

9.  Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial.

Authors:  A Halliday; A Mansfield; J Marro; C Peto; R Peto; J Potter; D Thomas
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

10.  Thrombolysis in a stroke patient on dabigatran anticoagulation: case report and synopsis of published cases.

Authors:  Waltraud Pfeilschifter; Mario Abruscato; Susanne Hövelmann; Horst Baas
Journal:  Case Rep Neurol       Date:  2013-03-25
View more
  5 in total

1.  Sirt1-ROS-TRAF6 Signaling-Induced Pyroptosis Contributes to Early Injury in Ischemic Mice.

Authors:  Weijie Yan; Wei Sun; Jiahui Fan; Haiqing Wang; Song Han; Junfa Li; Yanling Yin
Journal:  Neurosci Bull       Date:  2020-04-06       Impact factor: 5.203

2.  Gastrodin Inhibits Inflammasome Through the STAT3 Signal Pathways in TNA2 Astrocytes and Reactive Astrocytes in Experimentally Induced Cerebral Ischemia in Rats.

Authors:  Yue Sui; Ligong Bian; Qinglong Ai; Yueyi Yao; Mali Yu; Huiqing Gao; Aidan Zhang; Xiyue Fu; Lianmei Zhong; Di Lu
Journal:  Neuromolecular Med       Date:  2019-06-19       Impact factor: 3.843

3.  Ruscogenin Attenuates Cerebral Ischemia-Induced Blood-Brain Barrier Dysfunction by Suppressing TXNIP/NLRP3 Inflammasome Activation and the MAPK Pathway.

Authors:  Guosheng Cao; Nan Jiang; Yang Hu; Yuanyuan Zhang; Guangyun Wang; Mingzhu Yin; Xiaonan Ma; Kecheng Zhou; Jin Qi; Boyang Yu; Junping Kou
Journal:  Int J Mol Sci       Date:  2016-08-29       Impact factor: 5.923

4.  YiQiFuMai Powder Injection Protects against Ischemic Stroke via Inhibiting Neuronal Apoptosis and PKCδ/Drp1-Mediated Excessive Mitochondrial Fission.

Authors:  Yingqiong Xu; Yan Wang; Guangyun Wang; Xinyi Ye; Jiangwei Zhang; Guosheng Cao; Yazheng Zhao; Zhen Gao; Yuanyuan Zhang; Boyang Yu; Junping Kou
Journal:  Oxid Med Cell Longev       Date:  2017-12-24       Impact factor: 6.543

5.  Ketogenic Diet Improves Brain Ischemic Tolerance and Inhibits NLRP3 Inflammasome Activation by Preventing Drp1-Mediated Mitochondrial Fission and Endoplasmic Reticulum Stress.

Authors:  Min Guo; Xun Wang; Yanxin Zhao; Qi Yang; Hongyan Ding; Qiang Dong; Xingdong Chen; Mei Cui
Journal:  Front Mol Neurosci       Date:  2018-03-20       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.